Medicis CEO Keeps His Wits

The head of Medicis Pharmaceutical (MRX Quote) said Friday that he's continuing his effort to acquire Inamed (IMDC Quote) even though Allergan (AGN Quote) has made a competing bid.

Medicis Chairman and Chief Executive Jonah Shacknai said his company is proceeding with "all systems go" in pursuit of Inamed. He made the comments to investors at a Credit Suisse First Boston health care conference.

The company has filed a formal proxy with the Securities and Exchange Commission, set a Dec. 19 date for a shareholders' vote and filed answers to antitrust-related questions posed by the Federal Trade Commission. The FTC 30-day review period expires Dec. 14. ...